Metaplastic breast cancer: a review
Metaplastic breast cancer (MpBC) is an uncommon aggressive malignancy that is
associated with a poor prognosis. Due to its rarity, the relationships between the clinical and …
associated with a poor prognosis. Due to its rarity, the relationships between the clinical and …
[HTML][HTML] Molecular features of metaplastic breast carcinoma: an infrequent subtype of triple negative breast carcinoma
S González-Martínez, B Pérez-Mies, I Carretero-Barrio… - Cancers, 2020 - mdpi.com
Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent invasive
carcinomas that display differentiation of the neoplastic epithelium towards squamous cells …
carcinomas that display differentiation of the neoplastic epithelium towards squamous cells …
[HTML][HTML] Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
W Wong, E Brogi, JS Reis-Filho, G Plitas, M Robson… - NPJ breast …, 2021 - nature.com
Metaplastic breast carcinoma (MpBC) is a rare special histologic subtype of breast
carcinoma characterized by the presence of squamous and/or mesenchymal differentiation …
carcinoma characterized by the presence of squamous and/or mesenchymal differentiation …
[HTML][HTML] Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
Z Al-Hilli, G Choong, MG Keeney, DW Visscher… - Breast cancer research …, 2019 - Springer
Abstract Objective Metaplastic breast cancer (MetaBC) is a rare breast cancer subtype
poorly responsive to systemic therapy in the metastatic setting with high recurrence rates in …
poorly responsive to systemic therapy in the metastatic setting with high recurrence rates in …
Metaplastic breast cancer: prognostic and therapeutic considerations
G Corso, S Frassoni, A Girardi… - Journal of Surgical …, 2021 - Wiley Online Library
Introduction Metaplastic breast cancer (MBC) is a rare condition of breast tumor with different
subtypes, considered a disease with worse prognosis; treatments and survival are often …
subtypes, considered a disease with worse prognosis; treatments and survival are often …
[HTML][HTML] Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy
M Han, A Salamat, L Zhu, H Zhang, BZ Clark… - Modern Pathology, 2019 - Elsevier
Metaplastic breast carcinoma is a rare heterogeneous category of breast cancer, often
associated with a poor prognosis. Clinical-pathologic studies with respect to varied …
associated with a poor prognosis. Clinical-pathologic studies with respect to varied …
[HTML][HTML] Clinicopathological characteristics and prognosis of breast cancer with special histological types: a surveillance, epidemiology, and end results database …
Y Han, J Wang, B Xu - The Breast, 2020 - Elsevier
Objectives To explore the clinicopathological features and prognosis of breast cancer with
special histological types. Materials and methods The information of breast cancer patients …
special histological types. Materials and methods The information of breast cancer patients …
Metaplastic breast cancer: current understanding and future directions
A Thomas, E Douglas, JS Reis-Filho, MN Gurcan… - Clinical breast …, 2023 - Elsevier
Metaplastic breast cancers (MBC) encompass a group of highly heterogeneous tumors
which share the ability to differentiate into squamous, mesenchymal or neuroectodermal …
which share the ability to differentiate into squamous, mesenchymal or neuroectodermal …
AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2019
For almost 20 years, the Breast Committee of the German Gynecological Oncology Group
(Arbeitsgemeinschaft Gynäkologische Onkologie, AGO) has been preparing and updating …
(Arbeitsgemeinschaft Gynäkologische Onkologie, AGO) has been preparing and updating …
TROP2, androgen receptor, and PD‐L1 status in histological subtypes of high‐grade metaplastic breast carcinomas
S Chartier, C Brochard, C Martinat, F Coussy… - …, 2023 - Wiley Online Library
Aims High‐grade metaplastic breast carcinoma (HG‐MBC) is a rare subtype of invasive
breast carcinoma, mostly triple‐negative. Metaplastic carcinomas are less responsive to …
breast carcinoma, mostly triple‐negative. Metaplastic carcinomas are less responsive to …